Brain MRI findings in long-standing and disabling multiple sclerosis in 84 patients

Dimitri Renard1, Giovanni Castelnovo, Philippe-Jean Bousquet

  • 1Department of Neurology, CHU Nîmes, Hôpital Caremeau, Place du Pr Debré, 30029 Nîmes Cedex 4, France.

Abstract

Insights

In long-standing multiple sclerosis (MS), most patients show diffuse white matter changes on MRI, though typical criteria are met by most, not all. Diffuse leukoencephalopathy is common in disabling MS.

Area of Science:

  • Neurology
  • Radiology
  • Neuroimaging

Background:

  • Multiple Sclerosis (MS) is a chronic neurological disease characterized by demyelination and axonal damage.
  • Long-standing and disabling MS often involves significant cerebral white matter changes.
  • Standard MRI criteria (e.g., Barkhof's criteria) are used to diagnose MS and assess disease burden.

Purpose of the Study:

  • To investigate the prevalence and characteristics of cerebral white matter MRI changes in patients with long-standing and disabling MS.
  • To evaluate the extent to which these patients fulfill established MRI diagnostic criteria.

Main Methods:

  • Retrospective analysis of brain MRIs from 84 patients with MS diagnosis and Expanded Disability Status Scale (EDSS) of 6 or more, performed at least 10 years post-symptom onset.
  • Assessment of T2 hyperintensities (total, regional), T1 hypointensities, diffuse leukoencephalopathy score, and adherence to Barkhof's criteria.

Main Results:

  • The mean time from symptom onset to MRI was 20.2 years.
  • 94% of patients met Barkhof's criteria for MS MRI abnormalities; 6% did not.
  • Moderate or severe diffuse leukoencephalopathy was observed in 69% of patients, with 5% showing extensive nodular lesions.

Conclusions:

  • Even in long-standing, disabling MS, a small proportion of patients may not meet typical MRI criteria.
  • The majority of patients with severe MS exhibit significant diffuse white matter changes, particularly diffuse leukoencephalopathy, on MRI.